JérômeJ.LejeuneJérômeJ., MartheM.GauthierMartheM., RaymondR.TurpinRaymondR., Les chromosomes humains en culture de tissus, „Comptes Rendus Hebdomadaires des Séances de l'Académie des Sciences”, 248 (1), 1959, s. 602–603 [dostęp 2020-12-17](fr.).
O.C.O.C.WardO.C.O.C., John Langdon Down: the man and the message, „Down's Syndrome, Research and Practice: The Journal of the Sarah Duffen Centre”, 6 (1), 1999, s. 19–24, DOI: 10.3104/perspectives.94, ISSN0968-7912, PMID: 10890244 [dostęp 2020-12-17](ang.).
Joe HinJ.H.TjioJoe HinJ.H., AlbertA.LevanAlbertA., The chromosome number of man, „Hereditas”, 42 (1-2), 2010, s. 1–6, DOI: 10.1111/j.1601-5223.1956.tb03010.x [dostęp 2020-12-17](ang.).
Peter S.P.S.HarperPeter S.P.S., Fifty years of human chromosome abnormalities, „Human Genetics”, 126 (2), 2009, s. 322–324, DOI: 10.1007/s00439-009-0690-1(ang.).
MartheM.GautierMartheM., Cinquantenaire de la trisomie 21. Retour sur une découverte, „Medecine Sciences”, 25 (3), 2009, s. 311–315, DOI: 10.1051/medsci/2009253311, PMID: 19361398(fr.). Tłumaczenie na j. ang.: MartheM.GautierMartheM., Fiftieth anniversary of trisomy 21: returning to a discovery, „Human Genetics”, 126 (2), 2009, s. 317–322, DOI: 10.1007/s00439-009-0690-1(ang.).
M.B.M.B.PetersenM.B.M.B. i inni, Clinical, cytogenetic, and molecular genetic characterization of two unrelated patients with different duplications of 21q, „American Journal of Medical Genetics”, 7, Supplement: Trisomy 21 (Down Syndrome), 1990, s. 104–109, DOI: 10.1002/ajmg.1320370721, ISSN1040-3787, PMID: 2149934 [dostęp 2020-12-17](ang.).
Jin LiangJ.L.ZhuJin LiangJ.L. i inni, Paternal age and congenital malformations, „Human Reproduction (Oxford, England)”, 20 (11), 2005, s. 3173–3177, DOI: 10.1093/humrep/dei186, ISSN0268-1161, PMID: 16006461 [dostęp 2020-12-17](ang.).
P.A.P.A.BennP.A.P.A. i inni, Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results, „Prenatal Diagnosis”, 21 (1), 2001, s. 46–51, DOI: 10.1002/1097-0223(200101)21:1<46::AID-PD984>3.0.CO;2-C, ISSN0197-3851, PMID: 11180240 [dostęp 2020-12-17](ang.)..
Keith A. MDK.A.M.EddlemanKeith A. MDK.A.M. i inni, Pregnancy loss rates after midtrimester amniocentesis, „Obstetrics and Gynecology”, 108 (5), 2006, s. 1067–1072, DOI: 10.1097/01.AOG.0000240135.13594.07, PMID: 17077226(ang.).
C.C.MansfieldC.C., S.S.HopferS.S., T.M.T.M.MarteauT.M.T.M., Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review. European Concerted Action: DADA (Decision-making After the Diagnosis of a fetal Abnormality), „Prenatal Diagnosis”, 19 (9), 1999, s. 808–812, DOI: 10.1002/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.0.CO;2-B, ISSN0197-3851, PMID: 10521836 [dostęp 2020-12-17](ang.).
American Academy of Pediatrics, Committee on Genetics: Health supervision for children with Down syndrome, „Pediatrics”, 107 (2), 2001, s. 442–449, DOI: 10.1542/peds.107.2.442, ISSN1098-4275, PMID: 11158488 [dostęp 2020-12-17](ang.).
QuanheQ.YangQuanheQ., Sonja A.S.A.RasmussenSonja A.S.A., J.M.J.M.FriedmanJ.M.J.M., Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study, „The Lancet”, 359 (9311), 2002, s. 1019–1025, DOI: 10.1016/s0140-6736(02)08092-3, ISSN0140-6736, PMID: 11937181 [dostęp 2020-12-17](ang.).
David P.D.P.SteensmaDavid P.D.P., Down syndrome in Down House: trisomy 21, GATA1 mutations, and Charles Darwin, „Blood”, 105 (6), 2005, s. 2614–2616, DOI: 10.1182/blood-2004-10-3974, ISSN0006-4971, PMID: 15746086 [dostęp 2020-12-17](ang.).
O.C.O.C.WardO.C.O.C., John Langdon Down: the man and the message, „Down's Syndrome, Research and Practice: The Journal of the Sarah Duffen Centre”, 6 (1), 1999, s. 19–24, DOI: 10.3104/perspectives.94, ISSN0968-7912, PMID: 10890244 [dostęp 2020-12-17](ang.).
MartheM.GautierMartheM., Cinquantenaire de la trisomie 21. Retour sur une découverte, „Medecine Sciences”, 25 (3), 2009, s. 311–315, DOI: 10.1051/medsci/2009253311, PMID: 19361398(fr.). Tłumaczenie na j. ang.: MartheM.GautierMartheM., Fiftieth anniversary of trisomy 21: returning to a discovery, „Human Genetics”, 126 (2), 2009, s. 317–322, DOI: 10.1007/s00439-009-0690-1(ang.).
G.G.AllenG.G. i inni, Mongolism, „American Journal of Human Genetics”, 13 (4), 1961, s. 426, ISSN0002-9297, PMID: 17948460, PMCID: PMC1932135 [dostęp 2020-12-17](ang.). Przedruk z „The Lancet”, 1, 1961, s. 775(ang.).
M.B.M.B.PetersenM.B.M.B. i inni, Clinical, cytogenetic, and molecular genetic characterization of two unrelated patients with different duplications of 21q, „American Journal of Medical Genetics”, 7, Supplement: Trisomy 21 (Down Syndrome), 1990, s. 104–109, DOI: 10.1002/ajmg.1320370721, ISSN1040-3787, PMID: 2149934 [dostęp 2020-12-17](ang.).
Jin LiangJ.L.ZhuJin LiangJ.L. i inni, Paternal age and congenital malformations, „Human Reproduction (Oxford, England)”, 20 (11), 2005, s. 3173–3177, DOI: 10.1093/humrep/dei186, ISSN0268-1161, PMID: 16006461 [dostęp 2020-12-17](ang.).
P.A.P.A.BennP.A.P.A. i inni, Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results, „Prenatal Diagnosis”, 21 (1), 2001, s. 46–51, DOI: 10.1002/1097-0223(200101)21:1<46::AID-PD984>3.0.CO;2-C, ISSN0197-3851, PMID: 11180240 [dostęp 2020-12-17](ang.)..
Keith A. MDK.A.M.EddlemanKeith A. MDK.A.M. i inni, Pregnancy loss rates after midtrimester amniocentesis, „Obstetrics and Gynecology”, 108 (5), 2006, s. 1067–1072, DOI: 10.1097/01.AOG.0000240135.13594.07, PMID: 17077226(ang.).
C.C.MansfieldC.C., S.S.HopferS.S., T.M.T.M.MarteauT.M.T.M., Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review. European Concerted Action: DADA (Decision-making After the Diagnosis of a fetal Abnormality), „Prenatal Diagnosis”, 19 (9), 1999, s. 808–812, DOI: 10.1002/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.0.CO;2-B, ISSN0197-3851, PMID: 10521836 [dostęp 2020-12-17](ang.).
American Academy of Pediatrics, Committee on Genetics: Health supervision for children with Down syndrome, „Pediatrics”, 107 (2), 2001, s. 442–449, DOI: 10.1542/peds.107.2.442, ISSN1098-4275, PMID: 11158488 [dostęp 2020-12-17](ang.).
QuanheQ.YangQuanheQ., Sonja A.S.A.RasmussenSonja A.S.A., J.M.J.M.FriedmanJ.M.J.M., Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study, „The Lancet”, 359 (9311), 2002, s. 1019–1025, DOI: 10.1016/s0140-6736(02)08092-3, ISSN0140-6736, PMID: 11937181 [dostęp 2020-12-17](ang.).
David P.D.P.SteensmaDavid P.D.P., Down syndrome in Down House: trisomy 21, GATA1 mutations, and Charles Darwin, „Blood”, 105 (6), 2005, s. 2614–2616, DOI: 10.1182/blood-2004-10-3974, ISSN0006-4971, PMID: 15746086 [dostęp 2020-12-17](ang.).
O.C.O.C.WardO.C.O.C., John Langdon Down: the man and the message, „Down's Syndrome, Research and Practice: The Journal of the Sarah Duffen Centre”, 6 (1), 1999, s. 19–24, DOI: 10.3104/perspectives.94, ISSN0968-7912, PMID: 10890244 [dostęp 2020-12-17](ang.).
G.G.AllenG.G. i inni, Mongolism, „American Journal of Human Genetics”, 13 (4), 1961, s. 426, ISSN0002-9297, PMID: 17948460, PMCID: PMC1932135 [dostęp 2020-12-17](ang.). Przedruk z „The Lancet”, 1, 1961, s. 775(ang.).
M.B.M.B.PetersenM.B.M.B. i inni, Clinical, cytogenetic, and molecular genetic characterization of two unrelated patients with different duplications of 21q, „American Journal of Medical Genetics”, 7, Supplement: Trisomy 21 (Down Syndrome), 1990, s. 104–109, DOI: 10.1002/ajmg.1320370721, ISSN1040-3787, PMID: 2149934 [dostęp 2020-12-17](ang.).
Jin LiangJ.L.ZhuJin LiangJ.L. i inni, Paternal age and congenital malformations, „Human Reproduction (Oxford, England)”, 20 (11), 2005, s. 3173–3177, DOI: 10.1093/humrep/dei186, ISSN0268-1161, PMID: 16006461 [dostęp 2020-12-17](ang.).
P.A.P.A.BennP.A.P.A. i inni, Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results, „Prenatal Diagnosis”, 21 (1), 2001, s. 46–51, DOI: 10.1002/1097-0223(200101)21:1<46::AID-PD984>3.0.CO;2-C, ISSN0197-3851, PMID: 11180240 [dostęp 2020-12-17](ang.)..
C.C.MansfieldC.C., S.S.HopferS.S., T.M.T.M.MarteauT.M.T.M., Termination rates after prenatal diagnosis of Down syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review. European Concerted Action: DADA (Decision-making After the Diagnosis of a fetal Abnormality), „Prenatal Diagnosis”, 19 (9), 1999, s. 808–812, DOI: 10.1002/(SICI)1097-0223(199909)19:9<808::AID-PD637>3.0.CO;2-B, ISSN0197-3851, PMID: 10521836 [dostęp 2020-12-17](ang.).
American Academy of Pediatrics, Committee on Genetics: Health supervision for children with Down syndrome, „Pediatrics”, 107 (2), 2001, s. 442–449, DOI: 10.1542/peds.107.2.442, ISSN1098-4275, PMID: 11158488 [dostęp 2020-12-17](ang.).
QuanheQ.YangQuanheQ., Sonja A.S.A.RasmussenSonja A.S.A., J.M.J.M.FriedmanJ.M.J.M., Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study, „The Lancet”, 359 (9311), 2002, s. 1019–1025, DOI: 10.1016/s0140-6736(02)08092-3, ISSN0140-6736, PMID: 11937181 [dostęp 2020-12-17](ang.).
David P.D.P.SteensmaDavid P.D.P., Down syndrome in Down House: trisomy 21, GATA1 mutations, and Charles Darwin, „Blood”, 105 (6), 2005, s. 2614–2616, DOI: 10.1182/blood-2004-10-3974, ISSN0006-4971, PMID: 15746086 [dostęp 2020-12-17](ang.).